Home cervical
 

Keywords :   


Tag: cervical

New HPV vaccine from Merck strengthens cervical cancer protection

2014-12-10 22:43:17| Biotech - Topix.net

The drugmaker Merck & Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer.

Tags: protection cancer vaccine cervical

 

Experimental Cervical Cancer Vaccine Looks Promising in Trial

2014-10-02 06:35:36| Biotech - Topix.net

An experimental vaccine meant to protect against nine types of human papillomavirus could prevent 90 percent of all cervical cancers, a new study suggests. Researchers examined data from more than 2,500 women with precancerous cervical lesions and found that nearly all were caused by the nine types of HPV targeted by the vaccine being developed by Merck and Co.

Tags: trial cancer experimental promising

 
 

Comparison of Swine AI Procedures Between Traditional Cervical Catheters and a New Model of Hydraulic IUI under Field Conditions

2014-04-17 02:00:00| ThePigSite - Industry News

An experiment in Thailand reveals better results for artificial insemination of sows using a new catheter from Absolute Swine Insemination Co. than a conventional foam-tipped catheter; more sows were bred by seven days using two doses with the new catheter than with three doses using the foam device.

Tags: of under conditions field

 

Mercks Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study

2013-11-04 13:30:00| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION, N.J. Immunogenicity non-inferior to GARDASIL for original four HPV types Merck expects to file Biologics License Application with U.S. FDA in 2013 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that in the pivotal Phase III efficacy study, its investigational 9-valent HPV vaccine (V503) prevented approximately 97 percent of cervical, vaginal and vulvar pre-cancers caused by HPV types 31, 33, 45, 52, and 58. Language: English Contact: Media:Pamela Eisele, 908-423-5042orImraan Munshi, 215-652-0059orInvestor:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: in additional study iii

 

Sites : [1] [2]